Ultrasound Guided Peribulbar Anaesthesia - A Novel Dual Quadrant Injection Technique

May 28, 2015 updated by: Sunnybrook Health Sciences Centre

Ultrasound Guided Peribulbar Anaesthesia: a Real-time Ultrasound Guided Technique With a Novel Dual Quadrant Injection

Peribulbar anaesthesia for ocular surgery depends on the spread of local anaesthetic throught the orbit to be successful and has a relatively high failure rate. This study will examine a novel ultrasound guided approach to peribulbar anaesthesia which should extend the depostion of local anaesthetic by using a dual quadrant injection technique. The study will assess the feasibility of this technique, how successful it is and whether any obvious safety issues arise with its use.

Study Overview

Status

Completed

Conditions

Detailed Description

Peribulbar anesthesia is widely used for anterior and posterior chamber ophthalmic procedures. It is a blind technique which is traditionally carried out by inserting a needle in the infero-lateral aspect of the orbit below the globe and injecting a volume of 8 - 12 mL of local anesthetic in the periorbital space. The goal of this inejction is to achieve akinesia and anesthesia of the eye sufficient for surgery. The technique has a relatively high failure rate of up to 30%. A failure or insufficient block requires a second or rarely a third peribulbar injection to achieve success. Ultrasound can be used to guide needles in the human body and has been successfully used in many anatomic locations for anaesthesia. This study will assess whether ultrasound can guide the block needle in ophthalmic anesthesia to deliver local anesthetic via a single entry into two discrete locations within the periorbital space - the first in the infero-lateral quadrant and the second in the infero-medial quadrant. If this can be done the investigators may achieve a higher success rate for this block with a lower volume potentially improving the quality of the block and its safety.

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 88 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA score less than III and ability to provide a written informed consent
  • 22 patients presenting for opthalmic surgery

Exclusion Criteria:

  • Coagulation disorder or anticoagulated with INR > 1.5
  • Platelet count < 75 X 10*9/L
  • Significant Myopia (axial length > 28mm)
  • Patients unable to lie supine for 2 hours
  • Patients with recent gas or silicone injections in/around the eye

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: US Guided Dual Quadrant Peribulbar block
Ultrasound guided Dual Quadrant Peribulbar Anaesthesia
Landmark Guided single injection vs Ultrasound guided dual quadrant injection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Block Success
Time Frame: 10 minutes post intervention
Block will be deemed a failure if a supplementary block is required for the operative procedure
10 minutes post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Block Quality (standardized Ocular Scoring System for akinesia and anaesthesia)
Time Frame: 5 and 10 minutes
Block will be assessed according to a standardized Ocular Scoring System for akinesia and anaesthesia at 5 minutes and 10 minutes post block. This is a composite measure
5 and 10 minutes
Block Volume
Time Frame: 1 minute
Total volume of local anaesthetic will be recorded. Volume for each part of the dual injection technique will also be recorded. This is a composite measure.
1 minute
Duration of Procedure
Time Frame: 1 to 10 minutes
The duration of the entire procedure will be recorded
1 to 10 minutes
Complications
Time Frame: 6 Weeks
Any complications during the procedure or in follow up clinical visits will be recorded
6 Weeks
Image Visualization
Time Frame: 1 minute
Operator's ability to see the needle in both the infero-lateral and infero-medial injection will be recorded. Ability to see perineural, retrobulbar and medial rectus spread of local anaesthetic will be recorded. This is a composite qualitative measure.
1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul G McHardy, MD, Sunnybrook Health Sciences Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

March 20, 2015

First Submitted That Met QC Criteria

May 28, 2015

First Posted (Estimate)

June 2, 2015

Study Record Updates

Last Update Posted (Estimate)

June 2, 2015

Last Update Submitted That Met QC Criteria

May 28, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eye Diseases

Clinical Trials on Ultrasound guided Dual Quadrant Peribulbar Anaesthesia

3
Subscribe